ISOMERASE THERAPEUTICS LIMITED
Research and experimental development on biotechnology
ISOMERASE THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
First Floor Newnham Building Chesterford Research Park, Little Chesterford Cambridge CB10 1XL United Kingdom
Full company profile for ISOMERASE THERAPEUTICS LIMITED (08335008), an active life sciences and medical technology company based in Cambridge, United Kingdom. Incorporated 18 Dec 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Cash in Bank
£1.39M
Net Assets
£2.91M
Total Liabilities
£484.58k
Turnover
N/A
Employees
37
Debt Ratio
14%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Dec Year End | 2023 31 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Matthew Alan Gregory | Director | British | England | 18 Dec 2012 | Active |
| Steven James Moss | Director | British | England | 18 Dec 2012 | Active |
See all 5 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Matthew Alan Gregory
Ceased 5 Mar 2025
Steven James Moss
Ceased 5 Mar 2025
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
| Address | Tenure | Price Paid | Date Added |
|---|---|---|---|
Suite 4, Building 60, Chesterford Park, Little Chesterford, Saffron Walden (CB10 1XL) UTTLESFORD | Leasehold | - | 29 Sept 2021 |
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 24 Feb 2026 | Officers | Change to director Mr Robert Alec Booth on 24 Feb 2026 | |
| 16 Jan 2026 | Capital | Capital Return Purchase Own Shares Treasury Capital Date | |
| 13 Nov 2025 | Capital | Allotment of shares (GBP 9,012.51) on 12 Nov 2025 | |
| 6 Nov 2025 | Confirmation Statement | Confirmation statement made on 31 Oct 2025 with updates | |
| 14 May 2025 | Accounts | Annual accounts made up to 31 Dec 2024 |
Change to director Mr Robert Alec Booth on 24 Feb 2026
Capital Return Purchase Own Shares Treasury Capital Date
Allotment of shares (GBP 9,012.51) on 12 Nov 2025
Confirmation statement made on 31 Oct 2025 with updates
Annual accounts made up to 31 Dec 2024
Recent Activity
Latest Activity
Change to director Mr Robert Alec Booth on 24 Feb 2026
3 months ago on 24 Feb 2026
Capital Return Purchase Own Shares Treasury Capital Date
4 months ago on 16 Jan 2026
Allotment of shares (GBP 9,012.51) on 12 Nov 2025
6 months ago on 13 Nov 2025
Confirmation statement made on 31 Oct 2025 with updates
6 months ago on 6 Nov 2025
Annual accounts made up to 31 Dec 2024
1 years ago on 14 May 2025